1. Home
  2. HUN vs VIR Comparison

HUN vs VIR Comparison

Compare HUN & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huntsman Corporation

HUN

Huntsman Corporation

N/A

Current Price

$9.62

Market Cap

1.8B

Sector

Industrials

ML Signal

N/A

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$11.40

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUN
VIR
Founded
1970
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2004
2019

Fundamental Metrics

Financial Performance
Metric
HUN
VIR
Price
$9.62
$11.40
Analyst Decision
Hold
Strong Buy
Analyst Count
11
7
Target Price
$12.09
$19.43
AVG Volume (30 Days)
2.1M
1.8M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
2.64%
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
$5,683,000,000.00
$68,556,000.00
Revenue This Year
$3.08
$270.22
Revenue Next Year
$5.27
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.30
$4.75
52 Week High
$16.09
$11.94

Technical Indicators

Market Signals
Indicator
HUN
VIR
Relative Strength Index (RSI) 36.70 62.61
Support Level N/A $8.43
Resistance Level $10.60 $11.66
Average True Range (ATR) 0.32 0.64
MACD 0.02 0.16
Stochastic Oscillator 5.06 71.18

Price Performance

Historical Comparison
HUN
VIR

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. The product portfolio of the company comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, and others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. The company derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: